Diagnosis and management of asthma in preschool and school-age children: Focus on the 2007 NAEPP Guidelines

Current Opinion in Pulmonary Medicine

Volumn 15, Issue 1, 2009, Pages 52-56

  Horner, Caroline C ^a   Bacharier, Leonard B ^a  

^a University School of Medicine   (United States)

Author keywords

Asthma guidelines; Control; Severity

Indexed keywords

BECLOMETASONE; BUDESONIDE; CORTICOSTEROID; FLUTICASONE; MONTELUKAST; OMALIZUMAB; SALMETEROL;

ASTHMA; CLINICAL TRIAL; DISEASE CLASSIFICATION; DISEASE CONTROL; DISEASE COURSE; DISEASE EXACERBATION; DISEASE SEVERITY; EVIDENCE BASED MEDICINE; FORCED EXPIRATORY VOLUME; HEALTH; HUMAN; LOW DRUG DOSE; LUNG FUNCTION; MORBIDITY; PRACTICE GUIDELINE; RESEARCH; REVIEW; RISK ASSESSMENT; RISK FACTOR; SPIROMETRY;

ADMINISTRATION, INHALATION; ADRENAL CORTEX HORMONES; ASTHMA; CHILD; CHILD, PRESCHOOL; GUIDELINES AS TOPIC; HUMANS; INFANT; INFANT, NEWBORN; LUNG; SEVERITY OF ILLNESS INDEX; UNITED STATES;

EID: 58149271071     PISSN: 10705287     EISSN: 15316971     Source Type: Journal    
DOI: 10.1097/MCP.0b013e32831da8ea     Document Type: Review

References (21)

1. Expert Panel Report 3 (EPR-3). Guidelines for the diagnosis and management of asthma: summary report 2007. J Allergy Clin Immunol 2007; 120 (5 Suppl): S94-S138. This is the summary report of the Guidelines and is a comprehensive document including all recent recommendations and available evidence. The entire EPR3 Report is available online (http://www.nhlbi.nih.gov/ guidelines/asthma/asthgdln.htm).
2. Taussig LM, Wright AL, Holberg CJ, et al. Tucson Children's Respiratory Study: 1980 to present. J Allergy Clin Immunol 2003; 111:661-675. [quiz 676].
3. Castro-Rodriguez JA, Holberg CJ, Wright AL, Martinez FD. A clinical index to define risk of asthma in young children with recurrent wheezing. Am J Respir Crit Care Med 2000; 162 (4 Pt 1):1403-1406.
4. Fuhlbrigge AL, Kitch BT, Paltiel AD, et al. FEV(1) is associated with risk of asthma attacks in a pediatric population. J Allergy Clin Immunol 2001; 107:61-67.
5. Fuhlbrigge AL, Kitch BT, Paltiel AD, Kuntz KM. Forced expiratory volume in 1 s percentage improves the classification of severity among children with asthma. Pediatrics 2006; 118:e347-e355.
6. Liu AH, Zeiger R, Sorkness C, et al. Development and cross-sectional validation of the Childhood Asthma Control Test. J Allergy Clin Immunol 2007; 119:817-825.
7. Juniper EF, O'Byrne PM, Guyatt GH, et al. Development and validation of a questionnaire to measure asthma control. Eur Respir J 1999; 14:902-907.
8. Bacharier LB, Phillips BR, Bloomberg GR, et al. Severe intermittent wheezing in preschool children: a distinct phenotype. J Allergy Clin Immunol 2007; 119:604-610. This publication describes children with severe wheezing episodes separated by periods of wellness and proposes the term 'severe intermittent wheezing'.
9. Carroll CL, Schramm CM, Zucker AR. Severe exacerbations in children with mild asthma: characterizing a pediatric phenotype. J Asthma 2008; 45:513-517.
10. Bacharier LB, Strunk RC, Mauger D, et al. Classifying asthma severity in children: mismatch between symptoms, medication use, and lung function. Am J Respir Crit Care Med 2004; 170:426-432.
11. Galant SP, Morphew T, Amaro S, Liao O. Value of the bronchodilator response in assessing controller naive asthmatic children. J Pediatr 2007; 151:457-462. [462 e1]. This study describes a community population of children with asthma of varying severities not using controller therapy where the majority of subjects had a prebronchodilator FEV1 less than 80% predicted.
12. Gibson PG, Powell H. Written action plans for asthma: an evidence-based review of the key components. Thorax 2004; 59:94-99.
13. Borgmeyer A, Jamerson P, Gyr P, et al. The school nurse role in asthma management: can the action plan help? J Sch Nurs 2005; 21:23-30.
14. Szefler SJ, Phillips BR, Martinez FD, et al. Characterization of within-subject responses to fluticasone and montelukast in childhood asthma. J Allergy Clin Immunol 2005; 115:233-242.
15. Guilbert TW, Morgan WJ, Zeiger RS, et al. Long-term inhaled corticosteroids in preschool children at high risk for asthma. N Engl J Med 2006; 354:1985-1997.
16. Zeiger RS, Szefler SJ, Phillips BR, et al. Response profiles to fluticasone and montelukast in mild-to-moderate persistent childhood asthma J Allergy Clin Immunol 2006; 117:45-52.
17. Sorkness CA, Lemanske RF Jr, Mauger DT, et al. Long-term comparison of 3 controller regimens for mild-moderate persistent childhood asthma: the Pediatric Asthma Controller Trial. J Allergy Clin Immunol 2007; 119:64-72. This multicenter, double blind, randomized year-long trial of children 6-18 years of age with mild-to-moderate persistent asthma demonstrates the superiority of fluticasone therapy to montelukast therapy in terms of asthma control days, exacerbations, quality of life, and pulmonary function.
18. Szefler SJ, Baker JW, Uryniak T, et al. Comparative study of budesonide inhalation suspension and montelukast in young children with mild persistent asthma. J Allergy Clin Immunol 2007; 120:1043-1050.
19. Verberne AA, Frost C, Duiverman EJ, el al. Addition of salmeterol versus doubling the dose of beclomethasone in children with asthma: the Dutch Asthma Study Group. Am J Respir Crit Care Med 1998; 158:213-219.
20. Greenstone IR, Ni Chroinin MN, Masse V, et al. Combination of inhaled longacting beta2-agonists and inhaled steroids versus higher dose of inhaled steroids in children and adults with persistent asthma. Cochrane Database Syst Rev 2005:CD005533.
21. The Childhood Asthma Management Program Research Group. Long-term effects of budesonide or nedocromil in children with asthma. The Childhood Asthma Management Program Research Group. N Engl J Med 2000; 343:1054-1063.